Pharmaceutical Giants Invest in Virginia Pharma Training
AstraZeneca, Eli Lilly, and Merck have committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.
According to a memorandum of understanding signed by the companies and state entities, the training center will support the development of a skilled workforce in the region.
The pharmaceutical giants, each planning to build manufacturing facilities in Virginia, are partnering with the state government, including the Virginia Innovation Partnership Corp.
- AstraZeneca
- Eli Lilly & Co.
- Merck
The investment is expected to enhance the region's capabilities in advanced pharmaceutical manufacturing.
Author's summary: Pharma giants invest $120M in Virginia training center.
More News
- The long view on Brief Admission: autonomy and care for people with borderline personality disorder - National Elf Service
- Orthopaedic surgeon suggests anti-inflammatory diet tips for arthritis patients
- Owls hope to move past semifinal shortcomings in 2025-26 season
- Joao Pedro Guides Chelsea Past Lacklustre Tottenham in Fiery Derby
- Life Story: Raymond Frank Hills, 94; ‘Mayor’ Of East Millstone - The Franklin Reporter & Advocate
- WTA News: WTA roundup: Victoria Mboko reaches Hong Kong final
- The role of diet in feline diabetes mellitus | dvm360
- Far-right stoke anti-migrant riot in Dublin
- Best Moments from the Opening of the Grand Egyptian Museum